Literature DB >> 24323306

Normal cerebral FDG uptake during childhood.

Kevin London1, Robert Howman-Giles.   

Abstract

PURPOSE: Current understanding of cerebral FDG uptake during childhood originates from a small number of studies in patients with neurological abnormalities. Our aim was to describe cerebral FDG uptake in a dataset of FDG PET scans in children more likely to represent a normal population.
METHODS: We reviewed cerebral FDG PET scans in children up to 16 years of age with suspected/proven extracranial malignancies and the following exclusions: central nervous system metastases, previous malignancies, previous chemotherapy or radiotherapy, development of cerebral metastases during therapy, neurological conditions, taking antiepileptic medication or medications likely to interfere with cerebral metabolism, and general anaesthesia within 24 h. White matter, basal ganglia, thalamus and the cerebellar cortex were analysed using regional SUV(max), and the cerebral cortex, basal ganglia, thalamus and cerebellum were analysed using a regional relative uptake analysis in comparison to maximal cortical uptake.
RESULTS: Scans from 30 patients (age range 11 months to 16 years, mean age 10 years 5 months) were included. All regions showed increasing SUV(max) with age. The parietal, occipital, lateral temporal and medial temporal lobes showed lower rates of increasing FDG uptake causing changing patterns of regional FDG uptake during childhood. The cortical regions showing the most intense uptake in early childhood were the parietal and occipital lobes. At approximately 7 years of age these regions had relatively less uptake than the frontal lobes and at approximately 10 years of age these regions had relatively less uptake than the thalamus.
CONCLUSION: Relative FDG uptake in the brain has not reached an adult pattern by 1 year of age, but continues to change up to 16 years of age. The changing pattern is due to different regional rates of increasing cortical FDG uptake, which is less rapid in the parietal, occipital and temporal lobes than in the frontal lobes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24323306     DOI: 10.1007/s00259-013-2639-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  26 in total

1.  Brain development during childhood and adolescence: a longitudinal MRI study.

Authors:  J N Giedd; J Blumenthal; N O Jeffries; F X Castellanos; H Liu; A Zijdenbos; T Paus; A C Evans; J L Rapoport
Journal:  Nat Neurosci       Date:  1999-10       Impact factor: 24.884

Review 2.  Understanding anesthesia through functional imaging.

Authors:  Ramachandran Ramani; Richa Wardhan
Journal:  Curr Opin Anaesthesiol       Date:  2008-10       Impact factor: 2.706

3.  Synaptic pruning by microglia is necessary for normal brain development.

Authors:  Rosa C Paolicelli; Giulia Bolasco; Francesca Pagani; Laura Maggi; Maria Scianni; Patrizia Panzanelli; Maurizio Giustetto; Tiago Alves Ferreira; Eva Guiducci; Laura Dumas; Davide Ragozzino; Cornelius T Gross
Journal:  Science       Date:  2011-07-21       Impact factor: 47.728

Review 4.  A critical period of brain development: studies of cerebral glucose utilization with PET.

Authors:  H T Chugani
Journal:  Prev Med       Date:  1998 Mar-Apr       Impact factor: 4.018

5.  Global and local development of gray and white matter volume in normal children and adolescents.

Authors:  Marko Wilke; Ingeborg Krägeloh-Mann; Scott K Holland
Journal:  Exp Brain Res       Date:  2006-10-19       Impact factor: 1.972

6.  Intersubject variability of brain glucose metabolic measurements in young normal males.

Authors:  G J Wang; N D Volkow; A P Wolf; J D Brodie; R J Hitzemann
Journal:  J Nucl Med       Date:  1994-09       Impact factor: 10.057

7.  Developmental changes of cerebral blood flow and oxygen metabolism in children.

Authors:  T Takahashi; R Shirane; S Sato; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  1999-05       Impact factor: 3.825

8.  Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 15O water positron emission tomography study.

Authors:  W D Gaillard; T Zeffiro; S Fazilat; C DeCarli; W H Theodore
Journal:  Epilepsia       Date:  1996-06       Impact factor: 5.864

9.  The effect of carbamazepine on cerebral glucose metabolism.

Authors:  W H Theodore; E Bromfield; L Onorati
Journal:  Ann Neurol       Date:  1989-05       Impact factor: 10.422

10.  [Regional cerebral blood flow in children--normal value and regional distribution of cerebral blood flow in childhood].

Authors:  A Ogawa; N Nakamura; K Sugita; Y Sakurai; T Kayama; T Wada; J Suzuki
Journal:  No To Shinkei       Date:  1987-02
View more
  8 in total

Review 1.  2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.

Authors:  John Freebody; Eva A Wegner; Monica A Rossleigh
Journal:  World J Radiol       Date:  2014-10-28

Review 2.  Dose Estimation in Pediatric Nuclear Medicine.

Authors:  Frederic H Fahey; Alison B Goodkind; Donika Plyku; Kitiwat Khamwan; Shannon E O'Reilly; Xinhua Cao; Eric C Frey; Ye Li; Wesley E Bolch; George Sgouros; S Ted Treves
Journal:  Semin Nucl Med       Date:  2016-11-09       Impact factor: 4.446

3.  Age-associated reorganization of metabolic brain connectivity in Chinese children.

Authors:  Qi Huang; Jian Zhang; Tianhao Zhang; Hui Wang; Jianhua Yan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-13       Impact factor: 9.236

4.  Deep Brain Stimulation in a Case of Mitochondrial Disease.

Authors:  Daniel Martinez-Ramirez; Nawaz Hack; Matthew L Vasquez; Hokuto Morita; Juan C Giugni; Janine M Wolf; Janet Romrell; Pamela R Zeilman; Christopher W Hess; Kelly D Foote; Michael S Okun; Aparna Wagle Shukla
Journal:  Mov Disord Clin Pract       Date:  2015-09-29

5.  Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome.

Authors:  Agnieszka Zmyslowska; Bogdan Malkowski; Wojciech Fendler; Maciej Borowiec; Karolina Antosik; Piotr Gnys; Dobromila Baranska; Wojciech Mlynarski
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

6.  Pharmacokinetic modeling of [(18)F]fluorodeoxyglucose (FDG) for premature infants, and newborns through 5-year-olds.

Authors:  Kitiwat Khamwan; Donika Plyku; Shannon E O'Reilly; Alison Goodkind; Xinhua Cao; Frederic H Fahey; S Ted Treves; Wesley E Bolch; George Sgouros
Journal:  EJNMMI Res       Date:  2016-03-17       Impact factor: 3.138

7.  Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.

Authors:  Manuel Schütze; Danielle de Souza Costa; Jonas Jardim de Paula; Leandro Fernandes Malloy-Diniz; Carlos Malamut; Marcelo Mamede; Débora Marques de Miranda; Michael Brammer; Marco Aurélio Romano-Silva
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

Review 8.  How We Read Oncologic FDG PET/CT.

Authors:  Michael S Hofman; Rodney J Hicks
Journal:  Cancer Imaging       Date:  2016-10-18       Impact factor: 3.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.